When compared with controls, CILP-2 mRNA expression and protein levels were markedly increased in muscle tissues in T2DM patients (Figure 4A and C), whereas CILP-2 expression was reduced in the fat of T2DM individuals (Figure 4B and D). This evidence concerns the gene CILP2 and type 2 diabetes mellitus.